Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2017
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Endophthalmitis
- Focus Therapeutic Use
- 24 Oct 2017 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 24 Oct 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
- 13 Mar 2017 Status changed from not yet recruiting to recruiting.